{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T21:49:29Z","timestamp":1771883369455,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["421882\/2016-6"],"award-info":[{"award-number":["421882\/2016-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["421882\/2016-6"],"award-info":[{"award-number":["421882\/2016-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aurora kinases (AURKA and AURKB) are mitotic kinases with an important role in the regulation of several mitotic events, and in hematological malignancies,<jats:italic>AURKA<\/jats:italic>and<jats:italic>AURKB<\/jats:italic>hyperexpression are found in patients with cytogenetic abnormalities presenting a unfavorable prognosis. The aim of this study was evaluated the mRNA expression profile of pediatric Acute Lymphoblastic Leukaemia (ALL) patients and the efficacy of two<jats:italic>AURKA<\/jats:italic>and<jats:italic>AURKB<\/jats:italic>designed inhibitors (GW809897X and GW806742X) in a leukemia cell line as a potential novel therapy for ALL patients. Cellular experiments demonstrated that both inhibitors induced cell death with caspase activation and cell cycle arrest, however only the GW806742X inhibitor decreased with more efficacy<jats:italic>AURKA<\/jats:italic>and<jats:italic>AURKB<\/jats:italic>expression in K-562 leukemia cells. In ALL patients both<jats:italic>AURKA and AURKB<\/jats:italic>showed a significant overexpression, when compared to health controls. Moreover,<jats:italic>AURKB<\/jats:italic>expression level was significant higher than<jats:italic>AURKA<\/jats:italic>in patients, and predicted a poorer prognosis with significantly lower survival rates. No differences were found in<jats:italic>AURKA<\/jats:italic>and<jats:italic>AURKB<\/jats:italic>expression between gene fusions, immunophenotypic groups, white blood cells count, gender or age. In summary, the results in this study indicates that the<jats:italic>AURKA<\/jats:italic>and<jats:italic>AURKB<\/jats:italic>overexpression are important findings in pediatric ALL, and designed inhibitor, GW806742X tested in vitro were able to effectively inhibit the gene expression of both aurora kinases and induce apoptosis in K-562 cells, however our data clearly shown that<jats:italic>AURKB<\/jats:italic>proves to be a singular finding and potential prognostic biomarker that may be used as a promising therapeutic target to those patients.<\/jats:p>","DOI":"10.1038\/s41598-020-78024-8","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T11:03:23Z","timestamp":1607079803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia"],"prefix":"10.1038","volume":"10","author":[{"given":"Caroline Aquino","family":"Moreira-Nunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Pantoja","family":"Mesquita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrhyann Jullyanne de Sousa","family":"Portilho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Augusto Rodrigues","family":"Mello J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jersey Heitor da Silva","family":"Mau\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laudre\u00edsa da Costa","family":"Pantoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alayde Vieira","family":"Wanderley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Salim","family":"Khayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Zuercher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Carvalho","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoel Odorico","family":"de Moraes-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elisabete Amaral","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"78024_CR1","first-page":"518","volume-title":"Principles and Practice of Pediatric Oncology","author":"PA Pizzo","year":"2011","unstructured":"Pizzo, P. A. & Poplack, D. G. Principles and Practice of Pediatric Oncology 6th edn, 518\u2013527 (LWW, Philadelphia, 2011).","edition":"6"},{"key":"78024_CR2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation.V2012.1.389.3798360","volume-title":"The Molecular Genetic Makeup of Acute Lymphoblastic Leukemia","author":"CG Mullighan","year":"2012","unstructured":"Mullighan, C. G. The Molecular Genetic Makeup of Acute Lymphoblastic Leukemia (American Society of Hematology, Memphis, 2012)."},{"key":"78024_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07417.x","volume":"144","author":"CJ Harrison","year":"2009","unstructured":"Harrison, C. J. Cytogenetics of paediatric and adolescent acute lymphoblastic. Br. J. Haematol. 144, 147\u2013156 (2009).","journal-title":"Br. J. Haematol."},{"key":"78024_CR4","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","volume":"120","author":"C-H Pui","year":"2012","unstructured":"Pui, C.-H. et al. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?. Blood 120, 1165\u20131174 (2012).","journal-title":"Blood"},{"key":"78024_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/35048096","volume":"2","author":"EA Nigg","year":"2001","unstructured":"Nigg, E. A. Mitotic kinases as regulators of cell division and its check-points. Nat. Rev. Mol. Cell Biol. 2, 21\u201332 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"78024_CR6","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1038\/cddis.2012.148","volume":"3","author":"KS Chan","year":"2012","unstructured":"Chan, K. S., Koh, G. & Li, H. Y. Mitosis-targeted anti-cancer therapies: where they stand?. Cell Death Dis. 3, e411 (2012).","journal-title":"Cell Death Dis."},{"key":"78024_CR7","first-page":"5168","volume":"18","author":"T Ota","year":"2002","unstructured":"Ota, T. et al. Increased mitotic phosphorylation of histone H3 attributable to AIM-1\/Aurora-B overexpression contributes to chromosome number instability. Cancer Res. 18, 5168\u20135177 (2002).","journal-title":"Cancer Res."},{"key":"78024_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1471-2407-13-217","volume":"13","author":"S Yamamoto","year":"2013","unstructured":"Yamamoto, S. et al. A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer. BMC Cancer 13, 217 (2013).","journal-title":"BMC Cancer"},{"key":"78024_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/2159-8290.CD-11-0130","volume":"6","author":"H Beltran","year":"2011","unstructured":"Beltran, H. et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov. 6, 487\u2013495 (2011).","journal-title":"Cancer Discov."},{"key":"78024_CR10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1053\/j.gastro.2013.08.050","volume":"145","author":"A Katsha","year":"2013","unstructured":"Katsha, A. et al. Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia. Gastroenterology 145, 1312\u20131322 (2013).","journal-title":"Gastroenterology"},{"key":"78024_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/leu.2009.252","volume":"24","author":"CH Pui","year":"2009","unstructured":"Pui, C. H. et al. Long- term results of St Jude total therapy studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 24, 371\u2013382 (2009).","journal-title":"Leukemia"},{"key":"78024_CR12","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/leu.2008.251","volume":"22","author":"K Nguyen","year":"2008","unstructured":"Nguyen, K. et al. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children\u2019s Oncology Group study. Leukemia 22, 2142\u20132150 (2008).","journal-title":"Leukemia"},{"key":"78024_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nbt.3374","volume":"34","author":"JM Elkins","year":"2016","unstructured":"Elkins, J. M. et al. Comprehensive characterization of the published kinase inhibitor set. Nat. Biotecnol. 34, 95\u2013103 (2016).","journal-title":"Nat. Biotecnol."},{"key":"78024_CR14","first-page":"204","volume":"111","author":"IQ Magalhaes","year":"2000","unstructured":"Magalhaes, I. Q. et al. TEL\u2013AML1 fusion gene frequency in paediatric acute lymphoblastic leukaemia in Brazil. Br. J. Haematol. 111, 204\u2013207 (2000).","journal-title":"Br. J. Haematol."},{"key":"78024_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cancergencyto.2003.09.003","volume":"151","author":"PRG Zen","year":"2004","unstructured":"Zen, P. R. G. et al. Prevalence of TEL\/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 151, 68\u201372 (2004).","journal-title":"Cancer Genet. Cytogenet."},{"key":"78024_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cancergencyto.2008.09.005","volume":"188","author":"PR Zen","year":"2009","unstructured":"Zen, P. R. et al. ETV6\/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 188, 112\u2013117 (2009).","journal-title":"Cancer Genet. Cytogenet."},{"key":"78024_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.cancergen.2015.06.003","volume":"208","author":"TC Barbosa","year":"2015","unstructured":"Barbosa, T. C. et al. Frequency of copy number abnormalities in common genes associated with B-cell precursor acute lymphoblastic leukemia cytogenetic subtypes in Brazilian children. Cancer Genet. 208, 492\u2013501 (2015).","journal-title":"Cancer Genet."},{"key":"78024_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3109\/10428194.2011.565436","volume":"52","author":"MS Felice","year":"2011","unstructured":"Felice, M. S. et al. Prognostic impact of t(1;19)\/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Munster-based protocols. Leuk Lymphoma 52, 1215\u20131221 (2011).","journal-title":"Leuk Lymphoma"},{"key":"78024_CR19","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00277-018-3338-1","volume":"97","author":"Y Hong","year":"2018","unstructured":"Hong, Y. et al. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Ann. Hematol. 97, 1547\u20131554 (2018).","journal-title":"Ann. Hematol."},{"issue":"19","key":"78024_CR20","first-page":"2064","volume":"130","author":"SK Tasian","year":"2017","unstructured":"Tasian, S. K., Loh, M. L. & Hunger, S. P. Philadelphia chromosome\u2014like acute lymphoblastic leukemia. Blood J. Am. Soc. Hematol. 130(19), 2064\u20132072 (2017).","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"78024_CR21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts, K. G. et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N. Engl. J. Med. 371, 1005\u20131015 (2014).","journal-title":"N. Engl. J. Med."},{"key":"78024_CR22","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1200\/JCO.2014.55.4105","volume":"32","author":"KG Roberts","year":"2014","unstructured":"Roberts, K. G. et al. Outcomes of children with BCR-ABL1\u2014like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease. J. Clin. Oncol. 32, 3012\u20133020 (2014).","journal-title":"J. Clin. Oncol."},{"key":"78024_CR23","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.18632\/oncotarget.13492","volume":"8","author":"JM Boer","year":"2017","unstructured":"Boer, J. M. et al. Tyrosine kinase fusion genes in pediatric BCR- ABL1-like acute lymphoblastic leukemia. Oncotarget 8, 4618\u20134628 (2017).","journal-title":"Oncotarget"},{"key":"78024_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2014.14","volume":"34","author":"B Goldenson","year":"2015","unstructured":"Goldenson, B. & John, D. C. The aurora kinases in cell cycle and leukemia. Oncogene 34, 537 (2015).","journal-title":"Oncogene"},{"key":"78024_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.leukres.2010.07.034","volume":"35","author":"AR Lucena-Ara\u00fajo","year":"2011","unstructured":"Lucena-Ara\u00fajo, A. R. et al. High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia. Leuk Res. 35, 260\u2013264 (2011).","journal-title":"Leuk Res."},{"key":"78024_CR26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bjh.12518","volume":"163","author":"C M\u00fcller-Tidow","year":"2013","unstructured":"M\u00fcller-Tidow, C. et al. A randomized, open- label, phase I\/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory\/relapsed acute myeloid leukaemia. Br. J. Haematol. 163, 214\u2013222 (2013).","journal-title":"Br. J. Haematol."},{"key":"78024_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.exphem.2012.10.009","volume":"41","author":"FM Oliveira","year":"2013","unstructured":"Oliveira, F. M. et al. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH. Exp Hematol 41, 198\u2013208 (2013).","journal-title":"Exp Hematol"},{"key":"78024_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/jclinpath-2014-202728","volume":"68","author":"KR Genga","year":"2015","unstructured":"Genga, K. R. et al. Proteins of the mitotic checkpoint and spindle are related to chromosomal instability and unfavourable prognosis in patients with myelodysplastic syndrome. J. Clin. Pathol.. 68, 381\u2013387 (2015).","journal-title":"J. Clin. Pathol.."},{"key":"78024_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.leukres.2017.11.013","volume":"64","author":"BD de Paula","year":"2018","unstructured":"de Paula, B. D. et al. Prognostic importance of aurora kinases and mitotic spindle genes transcript levels in myelodysplastic syndrome. Leuk. Res. 64, 61\u201367 (2018).","journal-title":"Leuk. Res."},{"key":"78024_CR30","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1158\/0008-5472.CAN-09-2181","volume":"70","author":"KV Gleixner","year":"2010","unstructured":"Gleixner, K. V. et al. Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536. Cancer Res. 70, 1513\u20131523 (2010).","journal-title":"Cancer Res."},{"issue":"3","key":"78024_CR31","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/leu.2012.256","volume":"27","author":"SA Hartsink-Segers","year":"2013","unstructured":"Hartsink-Segers, S. A. et al. Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia 27(3), 560\u2013568 (2013).","journal-title":"Leukemia"},{"key":"78024_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","volume":"29","author":"CH Pui","year":"2011","unstructured":"Pui, C. H., Carroll, W. L., Meshinchi, S. & Arceci, R. J. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J. Clin. Oncol. 29, 551\u2013565 (2011).","journal-title":"J. Clin. Oncol."},{"key":"78024_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/aoms.2016.57577","volume":"1","author":"K Tari","year":"2016","unstructured":"Tari, K. et al. The role of BCR-ABL P190 in diagnosis and prognosis of aLL patients. Arch. Med. Lab. Sci. 1, 1\u201311 (2016).","journal-title":"Arch. Med. Lab. Sci."},{"issue":"5","key":"78024_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2141.2011.08898.x","volume":"155","author":"SS Farag","year":"2011","unstructured":"Farag, S. S. The potential role of Aurora kinase inhibitors in haematological malignancies. Br. J. Haematol. 155(5), 561\u2013579 (2011).","journal-title":"Br. J. Haematol."},{"key":"78024_CR35","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-07-0067","volume":"6","author":"T Ikezoe","year":"2007","unstructured":"Ikezoe, T. et al. A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia. Mol. Cancer Ther. 6, 1851\u20131857 (2007).","journal-title":"Mol. Cancer Ther."},{"key":"78024_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1535-6108(02)00235-0","volume":"3","author":"S Anand","year":"2003","unstructured":"Anand, S., Penrhyn-Lowe, S. & Venkitaraman, A. R. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3, 51\u201362 (2003).","journal-title":"Cancer Cell"},{"key":"78024_CR37","doi-asserted-by":"publisher","first-page":"23937","DOI":"10.18632\/oncotarget.14893","volume":"8","author":"A Tang","year":"2017","unstructured":"Tang, A. et al. Aurora kinases: novel therapy targets in cancers. Oncotarget 8, 23937\u201323954 (2017).","journal-title":"Oncotarget"},{"key":"78024_CR38","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1128\/MCB.25.12.4977-4992.2005","volume":"25","author":"HG Nguyen","year":"2005","unstructured":"Nguyen, H. G. et al. Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property. Mol. Cell. Biol. 25, 4977\u20134992 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"78024_CR39","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1096\/fj.09-130963","volume":"23","author":"HG Nguyen","year":"2009","unstructured":"Nguyen, H. G. et al. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J. 23, 2741\u20133274 (2009).","journal-title":"FASEB J."},{"key":"78024_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1541-7786.MCR-06-0208","volume":"5","author":"J Fu","year":"2007","unstructured":"Fu, J., Bian, M., Jiang, Q. & Zhang, C. Roles of aurora kinases in mitosis and tumorigenesis. Mol. Cancer Res. 5, 1\u201310 (2007).","journal-title":"Mol. Cancer Res."},{"key":"78024_CR41","doi-asserted-by":"publisher","first-page":"19525","DOI":"10.18632\/oncotarget.10657","volume":"9","author":"MD Gurden","year":"2018","unstructured":"Gurden, M. D. et al. Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: a key role for Aurora B in mitosis. Oncotarget 9, 19525 (2018).","journal-title":"Oncotarget"},{"key":"78024_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"T Otto","year":"2017","unstructured":"Otto, T. & Piotr, S. Cell cycle proteins as promising targets in cancer therapy. Nat. Rev. Cancer 17, 93\u2013115 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"78024_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758\u2013764 (2007).","journal-title":"Nature"},{"key":"78024_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","volume":"22","author":"KG Roberts","year":"2012","unstructured":"Roberts, K. G. et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 22, 153\u2013166 (2012).","journal-title":"Cancer Cell"},{"key":"78024_CR45","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ng.2287","volume":"44","author":"JR Downing","year":"2012","unstructured":"Downing, J. R. et al. The pediatric cancer genome project. Nat. Genet. 44, 619\u2013622 (2012).","journal-title":"Nat. Genet."},{"key":"78024_CR46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2174\/092986711794480203","volume":"18","author":"G Portella","year":"2011","unstructured":"Portella, G., Passaro, C. & Chieffi, P. Aurora B: a new prognostic marker and therapeutic target in cancer. Curr. Med. Chem. 18, 482\u2013496 (2011).","journal-title":"Curr. Med. Chem."},{"key":"78024_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5582\/irdr.2018.01018","volume":"7","author":"P Chieffi","year":"2018","unstructured":"Chieffi, P. Aurora B: a new promising therapeutic target in cancer. Intractable Rare Dis. Res. 7, 141\u2013144 (2018).","journal-title":"Intractable Rare Dis. Res."},{"key":"78024_CR48","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.4161\/cc.29267","volume":"13","author":"AM Spart\u00e0","year":"2014","unstructured":"Spart\u00e0, A. M. et al. Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia. Cell Cycle 13, 2237\u20132247 (2014).","journal-title":"Cell Cycle"},{"key":"78024_CR49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jcp.42.6.567","volume":"42","author":"JM Bennett","year":"1989","unstructured":"Bennett, J. M. et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J. Clin. Pathol. 42, 567\u2013584 (1989).","journal-title":"J. Clin. Pathol."},{"key":"78024_CR50","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","volume":"115","author":"V Conter","year":"2010","unstructured":"Conter, V. et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 115, 3206\u20133214 (2010).","journal-title":"Blood"},{"key":"78024_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tiv.2014.09.014","volume":"29","author":"F Bonnier","year":"2015","unstructured":"Bonnier, F. et al. Cell viability assessment using the Alamar blue assay: a comparison of 2D and 3D cell culture models. Toxicol In Vitro 29, 124\u2013131 (2015).","journal-title":"Toxicol In Vitro"},{"key":"78024_CR52","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611\u2013622 (2009).","journal-title":"Clin. Chem."},{"key":"78024_CR53","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. Analyzing real-time PCR data by the comparative Ct method. Nat. Protoc. 3, 1101\u20131107 (2008).","journal-title":"Nat. Protoc."},{"key":"78024_CR54","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk, D. et al. STRING v10: protein\u2013protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447\u2013D452 (2015).","journal-title":"Nucleic Acids Res."},{"key":"78024_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader, G. D. & Hogue, C. W. V. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 4, 81\u201390 (2003).","journal-title":"BMC Bioinform."},{"key":"78024_CR56","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8, S11 (2014).","journal-title":"BMC Syst. Biol."},{"key":"78024_CR57","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"78024_CR58","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2017","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, 2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78024-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T14:44:55Z","timestamp":1723992295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78024-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78024"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78024-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21272"}}